ERBB2 and breast cancer: Therewith, it will be interesting to test the potential role of CD16a-associated ADCC for NK cells of both origins (UC-NK cells, P-NK cells) against a Her2/Neu breast cancer cell line or other tumor cell lines (e.g., melanoma, colon cancer cell lines) in the presence of trastuzumab or equivalent drugs in future.